跳轉至內容
Merck
全部照片(1)

重要文件

EHU060091

Sigma-Aldrich

MISSION® esiRNA

targeting human SYVN1

登入查看組織和合約定價
全部照片(1)

About This Item

分類程式碼代碼:
41105324
NACRES:
NA.51
暫時無法取得訂價和供貨情況

描述

Powered by Eupheria Biotech

產品線

MISSION®

形狀

lyophilized powder

esiRNA cDNA 標靶序列

GCTGGAGGCAAGCTATGAACTTGCTCGCTGGCCCACCCCTAAGACTGGTACCCATTTCCTTTTCTTACCCTGATCTCCCCAGAAGCCTCTTGTGGTGGTGGCTGTGCCCCCTATGCCCTGTGGCATTTCTGCGTCTTACTGGCAACCACACAACTCAGGGAAAGGAATGCCTGGGAGTGGGGGTGCAGGCGGGCAGCACTGAGGGACCCTGCCCCGCCCCTCCCCCCAGGCCCCTTTCCTCTGCAGCTTCTCAAGTGAGACTGACCTGTCTCACCCAGCAGCCACTGCCCAGCCGCACTCCAGGCAAGGGCCAGTGCGCCTGCTCCTGACCACTGCAATCCCAGCGCCCAAGGAAGGCCACTTCTCAACTGGCAGAACTTCTGAAGTTTAGAATTGGAATTACTTCCTTACTAGTGTCTTTTGGCTTAAATTTTGTCTTTTGAAGTTGAATGCTTAATCCCGGGAAAGAGGAACAGGAGTGCCAGA

Ensembl | 人類登錄號

ENSG00000162298

NCBI登錄號

NM_172230

運輸包裝

ambient

儲存溫度

−20°C

基因資訊

human ... SYVN1(84447) , SYVN1(84447)

一般說明

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法律資訊

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

10 - Combustible liquids

閃點（°F）

Not applicable

閃點（°C）

Not applicable

從最近期的版本中選擇一個：

分析證明 (COA)

Lot/Batch Number
ZYU
OWU
MOU
QAS
KAS

未看到正確版本？

如果您需要一個特定的版本，您可以透過批號來尋找特定憑證。

搜尋 COA

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Yosuke Osaki et al.
Biochemical and biophysical research communications, 514(1), 217-223 (2019-04-29)
Mucopolysaccharidosis type II (MPS II) is one of the most common mucopolysaccharidoses, which is caused by mutation of the gene encoding iduronate 2-sulfatase (IDS). The loss of function of IDS leads to the accumulation of heparan sulfate and dermatan sulfate
Marioara Chiritoiu et al.
International journal of molecular sciences, 21(10) (2020-05-20)
Endoplasmic reticulum (ER)-associated degradation (ERAD) is the main mechanism of targeting ER proteins for degradation to maintain homeostasis, and perturbations of ERAD lead to pathological conditions. ER-degradation enhancing α-mannosidase-like (EDEM1) was proposed to extract terminally misfolded proteins from the calnexin

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務